Japanese encephalitis future or investigational therapies: Difference between revisions
(Created page with "__NOTOC__ {{Japanese encephalitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== ...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Japanese encephalitis}} | {{Japanese encephalitis}} | ||
{{CMG}} | |||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
There are a number of new vaccines under development. The mouse-brain derived vaccine is likely to be replaced by a cell-culture derived vaccine that is both safer and cheaper to produce. China licensed a live attenuated vaccine in 1988 and more than 200 million doses have been given; this vaccine is available in Nepal, Sri Lanka, South Korea and India. There is also a new chimeric vaccine based on the [[yellow fever 17D]] vaccine that is currently under development<ref name="Solomon">{{cite journal | volume=355 | pages=869-871 | year=2006 | issue=9 | title=Control of Japanese Encephalitis—within our grasp? | author=Tom Solomon | url=http://content.nejm.org/cgi/content/full/355/9/869 }}</ref>. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 16:34, 27 December 2012
Japanese encephalitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Japanese encephalitis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Japanese encephalitis future or investigational therapies |
FDA on Japanese encephalitis future or investigational therapies |
CDC on Japanese encephalitis future or investigational therapies |
Japanese encephalitis future or investigational therapies in the news |
Blogs on Japanese encephalitis future or investigational therapies |
Risk calculators and risk factors for Japanese encephalitis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
There are a number of new vaccines under development. The mouse-brain derived vaccine is likely to be replaced by a cell-culture derived vaccine that is both safer and cheaper to produce. China licensed a live attenuated vaccine in 1988 and more than 200 million doses have been given; this vaccine is available in Nepal, Sri Lanka, South Korea and India. There is also a new chimeric vaccine based on the yellow fever 17D vaccine that is currently under development[1].
References
- ↑ Tom Solomon (2006). "Control of Japanese Encephalitis—within our grasp?". 355 (9): 869–871.